Challenges and Strategies for Solubility Measurements and Dissolution Method Development for Amorphous Solid Dispersion Formulations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1550-7416
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Challenges and Strategies for Solubility Measurements and Dissolution Method Development for Amorphous Solid Dispersion Formulations ; volume:25 ; number:1 ; day:13 ; month:12 ; year:2022 ; pages:1-14 ; date:2.2023
The AAPS journal / American Association of Pharmaceutical Scientists ; 25, Heft 1 (13.12.2022), 1-14, 2.2023
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Hermans, Andre
Milsmann, Johanna
Li, Hanlin
Jede, Christian
Moir, Andrea
Hens, Bart
Morgado, James
Wu, Tian
Cohen, Michael
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1208/s12248-022-00760-8
- URN
-
urn:nbn:de:101:1-2023042821303148833725
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hermans, Andre
- Milsmann, Johanna
- Li, Hanlin
- Jede, Christian
- Moir, Andrea
- Hens, Bart
- Morgado, James
- Wu, Tian
- Cohen, Michael
- SpringerLink (Online service)
Ähnliche Objekte (12)
Synthesis of enhanced lipid solubility of indomethacin derivatives for topical formulations
Solubility vs Dissolution in Physiological Bicarbonate Buffer
The Need for Restructuring the Disordered Science of Amorphous Drug Formulations
Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation
Ethylenediamine Salt Enhances the Solubility and Dissolution of Flurbiprofen
Dissolution, solubility, and stability enhanced formulation strategies for the novel anti-infective corralopyronin A
Regorafenib Amorphous Solid Dispersions: Formulations, Properties and Biopharmaceutical Performance
Mineral dissolution and reprecipitation mediated by an amorphous phase
Solubility/Bioavailability Enhancement and Modified Release Formulations of Poorly Water-Soluble Drugs
Insights into the mechanism of enhanced dissolution in solid crystalline formulations
Lowering lattice forces in drug substance crystals to improve dissolution and solubility
Lowering lattice forces in drug substance crystals to improve dissolution and solubility
Synthesis of enhanced lipid solubility of indomethacin derivatives for topical formulations
Solubility vs Dissolution in Physiological Bicarbonate Buffer
The Need for Restructuring the Disordered Science of Amorphous Drug Formulations
Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation
Ethylenediamine Salt Enhances the Solubility and Dissolution of Flurbiprofen
Dissolution, solubility, and stability enhanced formulation strategies for the novel anti-infective corralopyronin A
Regorafenib Amorphous Solid Dispersions: Formulations, Properties and Biopharmaceutical Performance
Mineral dissolution and reprecipitation mediated by an amorphous phase
Solubility/Bioavailability Enhancement and Modified Release Formulations of Poorly Water-Soluble Drugs
Insights into the mechanism of enhanced dissolution in solid crystalline formulations
Lowering lattice forces in drug substance crystals to improve dissolution and solubility
Lowering lattice forces in drug substance crystals to improve dissolution and solubility
Synthesis of enhanced lipid solubility of indomethacin derivatives for topical formulations
Solubility vs Dissolution in Physiological Bicarbonate Buffer
The Need for Restructuring the Disordered Science of Amorphous Drug Formulations
Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation
Ethylenediamine Salt Enhances the Solubility and Dissolution of Flurbiprofen
Dissolution, solubility, and stability enhanced formulation strategies for the novel anti-infective corralopyronin A
Regorafenib Amorphous Solid Dispersions: Formulations, Properties and Biopharmaceutical Performance
Mineral dissolution and reprecipitation mediated by an amorphous phase
Solubility/Bioavailability Enhancement and Modified Release Formulations of Poorly Water-Soluble Drugs
Insights into the mechanism of enhanced dissolution in solid crystalline formulations
Lowering lattice forces in drug substance crystals to improve dissolution and solubility